| 1 |
Isoprenylcysteine carboxylmethyltransferase is associated with nasopharyngeal carcinoma chemoresistance and Ras activation
Zhu YB, Hu QY, Li H
Biochemical and Biophysical Research Communications, 516(3), 784, 2019 |
| 2 |
ICMT contributes to hepatocellular carcinoma growth, survival, migration and chemoresistance via multiple oncogenic pathways
Xu JG, Zhu Y, Wang F, Zhou Y, Xia GL, Xu W
Biochemical and Biophysical Research Communications, 518(3), 584, 2019 |
| 3 |
Isoprenylcysteine carboxylmethyltransferase regulates ovarian cancer cell response to chemotherapy and Ras activation
Liu Q, Chen J, Fu BB, Dai J, Zhao Y, Lai L
Biochemical and Biophysical Research Communications, 501(2), 556, 2018 |
| 4 |
Inhibiting prenylation augments chemotherapy efficacy in renal cell carcinoma through dual inhibition on mitochondrial respiration and glycolysis
Huang JR, Yang XY, Peng XC, Huang W
Biochemical and Biophysical Research Communications, 493(2), 921, 2017 |
| 5 |
Evaluation of substrate and inhibitor binding to yeast and human isoprenylcysteine carboxyl methyltransferases (Icmts) using biotinylated benzophenone-containing photoaffinity probes
Hahne K, Vervacke JS, Shrestha L, Donelson JL, Gibbs RA, Distefano MD, Hrycyna CA
Biochemical and Biophysical Research Communications, 423(1), 98, 2012 |
